Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
86 INR | +3.50% | +16.20% | -61.17% |
Valuation
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 20.71 | 19.67 | 18.02 | 14.21 | 51.77 | 375.4 |
Enterprise Value (EV) 1 | -9.817 | 16.22 | 6.84 | 6.119 | 51.7 | 697.8 |
P/E ratio | -8.38 x | 45.2 x | 17.8 x | 20.8 x | 92.6 x | 324 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 44.4 x | 0.53 x | 0.25 x | 0.26 x | 1.74 x | 21.6 x |
EV / Revenue | -21.1 x | 0.44 x | 0.09 x | 0.11 x | 1.74 x | 40.2 x |
EV / EBITDA | 4.13 x | 34.5 x | - | - | - | - |
EV / FCF | -0.31 x | -0.54 x | 0.91 x | -1.91 x | -3.96 x | -3.16 x |
FCF Yield | -324% | -185% | 110% | -52.3% | -25.3% | -31.6% |
Price to Book | 1.2 x | 1.11 x | 0.96 x | 0.73 x | 2.59 x | 17.7 x |
Nbr of stocks (in thousands) | 2,071 | 2,071 | 2,071 | 2,071 | 2,071 | 2,071 |
Reference price 2 | 10.00 | 9.500 | 8.700 | 6.860 | 25.00 | 181.2 |
Announcement Date | 17/10/18 | 06/09/19 | 05/12/20 | 03/09/21 | 05/09/22 | 07/09/23 |
Income Statement Evolution (Annual data)
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 0.466 | 37.19 | 73.09 | 55.13 | 29.71 | 17.35 |
EBITDA 1 | -2.379 | 0.4705 | - | - | - | - |
EBIT 1 | -2.41 | 0.4397 | 1.311 | 0.966 | 0.7709 | 1.652 |
Operating Margin | -517.1% | 1.18% | 1.79% | 1.75% | 2.59% | 9.52% |
Earnings before Tax (EBT) 1 | -2.47 | 0.4382 | 1.309 | 0.9225 | 0.7602 | 1.579 |
Net income 1 | -2.47 | 0.4382 | 1.021 | 0.6826 | 0.5626 | 1.168 |
Net margin | -530.05% | 1.18% | 1.4% | 1.24% | 1.89% | 6.73% |
EPS 2 | -1.193 | 0.2100 | 0.4900 | 0.3296 | 0.2700 | 0.5600 |
Free Cash Flow 1 | 31.83 | -30.02 | 7.517 | -3.198 | -13.06 | -220.8 |
FCF margin | 6,829.49% | -80.71% | 10.28% | -5.8% | -43.94% | -1,272.41% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | 736.42% | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 17/10/18 | 06/09/19 | 05/12/20 | 03/09/21 | 05/09/22 | 07/09/23 |
Balance Sheet Analysis
Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 322 |
Net Cash position 1 | 30.5 | 3.46 | 11.2 | 8.09 | 0.07 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - |
Free Cash Flow 1 | 31.8 | -30 | 7.52 | -3.2 | -13.1 | -221 |
ROE (net income / shareholders' equity) | -13.3% | 2.51% | 5.6% | 3.57% | 2.85% | 5.68% |
ROA (Net income/ Total Assets) | -1% | 0.35% | 1.44% | 1.14% | 1.42% | 0.54% |
Assets 1 | 247.1 | 125.7 | 70.91 | 59.94 | 39.69 | 215 |
Book Value Per Share 2 | 8.340 | 8.550 | 9.040 | 9.390 | 9.660 | 10.20 |
Cash Flow per Share 2 | 15.70 | 1.670 | 5.400 | 3.910 | 0.0400 | 0.1200 |
Capex | - | - | - | - | - | 192 |
Capex / Sales | - | - | - | - | - | 1,105.73% |
Announcement Date | 17/10/18 | 06/09/19 | 05/12/20 | 03/09/21 | 05/09/22 | 07/09/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-61.17% | 18.58M | |
+12.56% | 37.59B | |
-.--% | 11.91B | |
+27.72% | 7.66B | |
-8.72% | 7.18B | |
+9.30% | 6.91B | |
-11.33% | 5.52B | |
-2.72% | 5.14B | |
+24.49% | 4.9B | |
+4.02% | 3.88B |
- Stock Market
- Equities
- ABVL Stock
- Financials Arunjyothi Bio Ventures Limited